Scheduled For: Wednesday, February 7th, 2018 View all Events
|Date:||February 7-9, 2018|
|Location:||New York City, NY|
Neoantigen Approaches for Biomarkers
Daniel Duncan, M.D. | Medical Director and Director, Translational NGS
February 8, 2018 | 1:25 pm EST
This talk will include data that demonstrates how Cancer Genetics leveraged NGS with advanced computational analysis to identify novel expressed mutations and algorithmically estimate the binding affinity of the translated protein to the major histocompatibility complex haplotypes encoded by each genome. Their IO Complete workflow can be utilized to both characterize overall somatic mutation burden and neoantigen burden, and validate predicted epitopes as a precursor to designing novel therapeutic agents.
[formidable id=12 title=true description=true]